三尖瓣反流在肺动脉高压及不同WHO分型中的预后价值
本研究回顾性纳入1318例超声心动图右室收缩压≥50 mm Hg且测量了右室游离壁纵向应变的患者,排除左侧瓣膜病、左室射血分数降低等情况。中位随访1.5年,454例死亡,结果显示中度及以上继发性三尖瓣反流独立于右室功能指标和右室-肺动脉耦联预测全因死亡,且在各WHO分型中均保持该预后意义。
要点
- 中度及以上继发性三尖瓣反流提示肺动脉高压患者死亡风险升高,报告应明确分级。
- 该预后价值独立于右室功能障碍及右室-肺动脉耦联,不能仅以右室功能解释。
- 各WHO分型肺动脉高压中均适用,阅片及随访时需关注三尖瓣反流程度变化。
核心结论
- 中度或重度继发性三尖瓣反流在不伴左侧瓣膜病或左室射血分数降低的肺动脉高压患者中增加死亡风险,独立于右室功能障碍和右室-肺动脉耦联受损。
研究设计与样本
- 回顾性研究,纳入2010年至2023年间超声心动图右室收缩压≥50 mm Hg且测量右室游离壁纵向应变的1318例患者。
- 排除原发性三尖瓣疾病、左室射血分数降低、显著左侧瓣膜病、先天性心脏病、失代偿期肝硬化、恶性肿瘤及透析患者。
- 肺动脉高压按WHO分型分类,随访终点为全因死亡。
关键影像表现/征象
- 1318例患者中29%存在中度及以上继发性三尖瓣反流,中位右室游离壁纵向应变为19%。
- 中度及以上三尖瓣反流患者症状更重、充血表现更多,右室功能和肺动脉压力更差。
- WHO第1、2、3、4型肺动脉高压占比分别为33%、11%、32%和12%。
诊断标准与关键数值
- 中度或重度继发性三尖瓣反流与全因死亡相关,且独立于多种右室功能指标及右室-肺动脉耦联。
- 该预后关联在各WHO肺动脉高压分型中均成立。
- 入组条件为超声心动图右室收缩压≥50 mm Hg,中位随访1.5年(Q1-Q3:0.3-4.6年),454例患者死亡。
临床应用与阅片要点
- 在肺动脉高压患者超声报告中,对继发性三尖瓣反流应进行半定量分级,中度及以上应视为独立危险标志。
- 评估肺动脉高压预后时,不应仅依据右室功能或右室-肺动脉耦联,三尖瓣反流程度需单独纳入判断。
- 各WHO分型的肺动脉高压患者均应重视三尖瓣反流的动态变化,作为随访中的风险分层参考。
局限性
- 回顾性单中心设计,可能存在选择偏倚和混杂。
- 三尖瓣反流严重程度的评估依赖超声操作者,分级可能受主观影响。
- 中位随访时间较短,长期预后价值需要进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Secondary tricuspid regurgitation (STR) is frequently observed in patients with pulmonary hypertension (PH). Whether it independently confers mortality risk beyond the associated right ventricular (RV) dysfunction remains unknown.
OBJECTIVES: The aim of this study was to evaluate the prognostic significance of STR in patients with PH other than related to left-sided valve disease or reduced ejection fraction and across the individual WHO (World Health Organization) groups of PH.
METHODS: Patients with RV systolic pressures ≥50 mm Hg on echocardiography between 2010 and 2023 and measured RV free wall longitudinal strain were identified retrospectively. Primary tricuspid valve disease, reduced left ventricular ejection fraction, significant left-sided valve disease, congenital heart disease, decompensated cirrhosis, malignancy, and dialysis were exclusion criteria. PH was classified according to the WHO group classification. Patients were followed for all-cause mortality.
RESULTS: Of 1,318 patients (mean age 67 years, 61% women, 29% with moderate or greater STR, median RV free wall longitudinal strain 19%), WHO groups 1, 2, 3, and 4 PH were present in 33%, 11%, 32%, and 12%, respectively. Patients with moderate or greater STR were more symptomatic and congested and had worse RV function and pulmonary pressures. Over a median 1.5 years (Q1-Q3: 0.3-4.6 years), 454 patients died. Moderate or severe STR was associated with mortality independent of various RV function measures or RV-pulmonary arterial coupling. This remained true across the individual WHO groups of PH.
CONCLUSIONS: Moderate or severe STR conferred mortality risk in patients with PH without left-sided valve disease or reduced left ventricular ejection fraction, beyond what can be explained by the associated RV dysfunction or impaired RV-pulmonary arterial coupling. Whether STR may represent an additional therapeutic target in certain subgroups with PH requires future investigation.
引用
- Naser, Ibrahim, Rahme, et al. Prognostic Value of Tricuspid Regurgitation in Pulmonary Hypertension and Among the Different WHO Groups. JACC Cardiovasc Imaging. 2026. PMID: 42268173. doi:10.1016/j.jcmg.2026.04.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。